Shareholders are set to vote on Thursday whether to back the gene-sequencing company?s incumbent board or candidates named by the activist investor.
As said here by BY ANDREW ROSS SORKIN, BERNHARD WARNER, SARAH KESSLER, MICHAEL J. DE LA MERCED, LAUREN HIRSCH AND EPHRAT LIVNI